Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
17.26
-0.05 (-0.29%)
At close: Feb 6, 2026
Shanghai Pharmaceuticals Holding Employees
Shanghai Pharmaceuticals Holding had 50,120 employees as of June 30, 2025. The number of employees increased by 718 or 1.45% since the number was reported on December 31, 2024.
Employees
50,120
Change
718
Growth
1.45%
Revenue / Employee
5.68M CNY
Profits / Employee
114.28K CNY
Market Cap
57.78B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 50,120 | 718 | 1.45% |
| Dec 31, 2024 | 49,402 | 1,238 | 2.57% |
| Dec 31, 2023 | 48,164 | 287 | 0.60% |
| Dec 31, 2022 | 47,877 | 821 | 1.74% |
| Dec 31, 2021 | 47,056 | -1,080 | -2.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| China National Accord Medicines Corporation | 39,449 |
| Jointown Pharmaceutical Group | 30,169 |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 27,425 |
| C.Q. Pharmaceutical Holding | 13,820 |
| China Meheco Group | 8,368 |
| Guangxi LiuYao Group | 5,513 |
| Liaoning Cheng Da | 3,317 |
| China National Medicines Corporation | 3,104 |
Shanghai Pharmaceuticals Holding News
- 1 year ago - Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million - Benzinga
- 1 year ago - HUTCHMED to divest 45% stake in JV with Shanghai Pharma - Seeking Alpha